Eli Casdin: insider trades and track record
As of Jun 8, 2026, Eli Casdin filed 19 open-market purchases worth $23.2M and 3 sales worth $95.5M in 3 companies since May 15, 2024, from Form 4 filings. At the latest insider trade price in each stock, 6 of 19 purchases are worth more than the price paid (median change -51%).
Latest filing Jun 8, 2026. From Form 4 filings. Data only, not investment advice.
At a glance
Track record by company
One row per company: what they paid, what they got for shares sold later, and how the shares they still hold compare with the latest insider trade price.
| Stock | Role | Bought | Avg price paid | Result on shares sold | Shares still held | Latest price | Change on held shares |
|---|---|---|---|---|---|---|---|
| WGS | Director | $15.4M | $37.51 | +495% on 210,000 sh | 200,000 | $96.90 Sep 16, 2026 | +74% |
| LAB | Director | $7.9M | $1.75 | – | 4.49M | $0.63 Nov 5, 2026 | -64% |
1.79M shares sold were not bought in the open market in our data (stock awards, options or purchases before Nov 17, 2023), so they have no return.
Every purchase and the latest price
Each open-market purchase, next to the most recent price any insider paid or received for the same stock.
| Date | Stock | Shares | Price paid | Value | Latest price | Change |
|---|---|---|---|---|---|---|
| Jun 5, 2026 | WGS | 50,000 | $52.86 | $2.6M | $96.90 Sep 16, 2026 | +83% |
| Jun 4, 2026 | WGS | 150,000 | $56.44 | $8.5M | $96.90 Sep 16, 2026 | +72% |
| Nov 20, 2025 | LAB | 450,000 | $1.30 | $585K | $0.63 Nov 5, 2026 | -52% |
| Nov 19, 2025 | LAB | 350,000 | $1.28 | $448K | $0.63 Nov 5, 2026 | -51% |
| Nov 18, 2025 | LAB | 275,000 | $1.23 | $338K | $0.63 Nov 5, 2026 | -49% |
| Sep 4, 2025 | LAB | 250,000 | $1.28 | $320K | $0.63 Nov 5, 2026 | -51% |
| Sep 3, 2025 | LAB | 250,000 | $1.27 | $318K | $0.63 Nov 5, 2026 | -51% |
| Aug 15, 2025 | LAB | 150,000 | $1.22 | $183K | $0.63 Nov 5, 2026 | -49% |
| Aug 14, 2025 | LAB | 133,220 | $1.21 | $161K | $0.63 Nov 5, 2026 | -48% |
| Aug 13, 2025 | LAB | 75,000 | $1.31 | $98.2K | $0.63 Nov 5, 2026 | -52% |
| Aug 5, 2024 | LAB | 200,000 | $1.58 | $316K | $0.63 Nov 5, 2026 | -60% |
| Aug 2, 2024 | LAB | 1.00M | $1.63 | $1.6M | $0.63 Nov 5, 2026 | -62% |
| May 29, 2024 | WGS | 40,000 | $21.07 | $843K | $96.90 Sep 16, 2026 | +360% |
| May 28, 2024 | WGS | 18,304 | $20.61 | $377K | $96.90 Sep 16, 2026 | +370% |
| May 24, 2024 | WGS | 144,196 | $20.12 | $2.9M | $96.90 Sep 16, 2026 | +382% |
| May 23, 2024 | WGS | 7,500 | $19.59 | $147K | $96.90 Sep 16, 2026 | +395% |
| May 17, 2024 | LAB | 352,072 | $2.56 | $901K | $0.63 Nov 5, 2026 | -76% |
| May 16, 2024 | LAB | 500,000 | $2.54 | $1.3M | $0.63 Nov 5, 2026 | -75% |
| May 15, 2024 | LAB | 500,000 | $2.57 | $1.3M | $0.63 Nov 5, 2026 | -76% |
How this track record is worked out
- Only open-market purchases and sales (Form 4 codes P and S) from the last 3 years. Shares received as pay, from options or before that window are not purchases, so they never count toward a return.
- Result on shares sold matches each sale with this insider's own earlier purchases in the same company, oldest first, using the prices in their filings.
- Latest price is the price of the most recent open-market trade any insider filed in that company, with its date. It is not a live stock quote, and it is not shown when it is more than 120 days old.
- Prices are adjusted for stock splits, found when the company's shares outstanding (from its 10-Q and 10-K covers) and the trade prices move by the same split ratio.
- A trade reported jointly by several owners (a fund, its manager, its partners) is shown once, under the first owner named in the filing.
- Past results say nothing about future trades. This is a record of filings, not a recommendation.
All open-market trades
Purchases and sales by month for the last 3 years. Click a month to see only its trades.
| Date | Stock | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 5, 2026 | WGS | Eli Casdin +3 | Director | Purchase | 50,000 | $52.86 | $2.6M | Form 4 |
| Jun 4, 2026 | WGS | Eli Casdin +3 | Director | Purchase | 150,000 | $56.44 | $8.5M | Form 4 |
| Nov 20, 2025 | LAB | Eli Casdin +7 | Director | Purchase | 450,000 | $1.30 | $585K | Form 4 |
| Nov 19, 2025 | LAB | Eli Casdin +7 | Director | Purchase | 350,000 | $1.28 | $448K | Form 4 |
| Nov 18, 2025 | LAB | Eli Casdin +7 | Director | Purchase | 275,000 | $1.23 | $338K | Form 4 |
| Sep 4, 2025 | LAB | Eli Casdin +7 | Director | Purchase | 250,000 | $1.28 | $320K | Form 4 |
| Sep 3, 2025 | LAB | Eli Casdin +7 | Director | Purchase | 250,000 | $1.27 | $318K | Form 4 |
| Aug 22, 2025 | WGS | Eli Casdin +3 | Director | Sale | 500,000 | $120.90 | $60.5M | Form 4 |
| Aug 15, 2025 | LAB | Eli Casdin +7 | Director | Purchase | 150,000 | $1.22 | $183K | Form 4 |
| Aug 14, 2025 | LAB | Eli Casdin +7 | Director | Purchase | 133,220 | $1.21 | $161K | Form 4 |
| Aug 13, 2025 | LAB | Eli Casdin +7 | Director | Purchase | 75,000 | $1.31 | $98.2K | Form 4 |
| Aug 11, 2025 | BLFS | Eli Casdin +3 | 10% owner | Sale | 500,000 | $22.60 | $11.3M | Form 4 |
| Jun 10, 2025 | BLFS | Eli Casdin +3 | 10% owner | Sale | 1.00M | $23.80 | $23.8M | Form 4 |
| Aug 5, 2024 | LAB | Eli Casdin +8 | Director | Purchase | 200,000 | $1.58 | $316K | Form 4 |
| Aug 2, 2024 | LAB | Eli Casdin +8 | Director | Purchase | 1.00M | $1.63 | $1.6M | Form 4 |
| May 29, 2024 | WGS | Eli Casdin +4 | Director | Purchase | 40,000 | $21.07 | $843K | Form 4 |
| May 28, 2024 | WGS | Eli Casdin +4 | Director | Purchase | 18,304 | $20.61 | $377K | Form 4 |
| May 24, 2024 | WGS | Eli Casdin +4 | Director | Purchase | 144,196 | $20.12 | $2.9M | Form 4 |
| May 23, 2024 | WGS | Eli Casdin +4 | Director | Purchase | 7,500 | $19.59 | $147K | Form 4 |
| May 17, 2024 | LAB | Eli Casdin +8 | Director | Purchase | 352,072 | $2.56 | $901K | Form 4 |
| May 16, 2024 | LAB | Eli Casdin +8 | Director | Purchase | 500,000 | $2.54 | $1.3M | Form 4 |
| May 15, 2024 | LAB | Eli Casdin +8 | Director | Purchase | 500,000 | $2.57 | $1.3M | Form 4 |
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.